GENinCode Plc (AIM: GENI) shares rose around 23% in early trading after the predictive genetics company reported encouraging clinical results for its CARDIO inCode-Score® test in the prevention of coronary
Six Biotechs to Watch in 2026: Breakthroughs, Setbacks, and Big Turning Points Ahead
The biotechnology market has delivered a mixed landscape in 2025, shaped by shifting investor sentiment, ongoing regulatory pressures, and the continued search for differentiated clinical assets. Against this backdrop several
Six Biotechs to Watch in 2026: Breakthroughs, Setbacks, and Big Turning Points Ahead
The biotechnology market has delivered a mixed landscape in 2025, shaped by shifting investor sentiment, ongoing regulatory pressures, and the continued search for differentiated clinical assets. Against this backdrop several